Serum Periostin Predicts Wheezing Exacerbation: A Prospective Study in Preschool Children with Recurrent Wheezing

Author:

Yooma Pailin,Manuyakorn Wiparat,Sawatchai Adithep,Jotikasthira Wanlapa,Kiewngam Potjanee,Kanchongkittiphon Watcharoot

Abstract

<b><i>Introduction:</i></b> Wheezing is a common problem in preschool children. Currently, there are no reliable biomarkers that can predict subsequent wheezing in preschool children. This study aimed to compare serum periostin levels between preschool children with and without recurrent wheezing and investigate its utility for predicting acute wheezing exacerbation. <b><i>Methods:</i></b> Children aged 2–5 years with recurrent wheezing and healthy control children were enrolled. They were evaluated for serum periostin level at enrollment and subsequently followed for wheezing episodes in a 1-year prospective study. <b><i>Results:</i></b> A total of 122 children were enrolled. Children in the recurrent wheezing group (<i>n</i> = 80) had a greater median serum periostin level (1,122.32 pg/mL [&#x3c;10–6,978.93]) than that of the healthy control group (<i>n</i> = 40) (&#x3c;10 pg/mL [&#x3c;10–2,116.69]), <i>p</i> value = 0.006. After 1-year follow-up, subjects who experienced subsequent wheezing exacerbation episodes had a greater median of periostin level (5,321 pg/mL) compared with those with no exacerbation (&#x3c;10 pg/mL), <i>p</i> value = 0.014. ROC curve analysis revealed that the level of serum periostin &#x3e;1,200 pg/mL, corresponding to 78.9% sensitivity and 64.6% specificity, with an AUC of 0.701, <i>p</i> value = 0.009, could be a predictor for acute wheezing exacerbation within 1 year. Besides, subjects with serum periostin &#x3e;1,200 pg/mL had greater odds of subsequent wheezing episodes compared with those with lower levels of serum periostin (adjusted odds ratio 10.0, 95% confidence interval: 2.3–43.5). <b><i>Conclusions:</i></b> Preschool children with recurrent wheezing have a greater serum periostin level than healthy control. Serum periostin may be a valuable biomarker for predicting acute wheezing exacerbations in the following year.

Publisher

S. Karger AG

Subject

Immunology,General Medicine,Immunology and Allergy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3